Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Lymph Node Excision
  • Lymphatic Metastasis
  • Neoplasm Recurrence, Local
  • Sentinel Lymph Node

abstract

  • Despite the potential for residual axillary disease after SLND, SLND without ALND offers excellent regional control for selected patients with early metastatic breast cancer treated with breast-conserving therapy and adjuvant systemic therapy.

publication date

  • August 17, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5070540

Digital Object Identifier (DOI)

  • 10.1097/SLA.0000000000001863

PubMed ID

  • 27513155

Additional Document Info

start page

  • 413

end page

  • 20